During the past decade, Reparto Di Neurologia dell'Osperdale Di Padova conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Reparto Di Neurologia dell'Osperdale Di Padova" are "Duchenne Muscular Dystrophy" (1 trials) and "Duchenne Muscular Dystrophy (DMD)" (1 trials). Many other conditions were trialed in "Reparto Di Neurologia dell'Osperdale Di Padova" in a lesser frequency.

Most popular intervention types in "Reparto Di Neurologia dell'Osperdale Di Padova" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Idebenone 150 mg film-coated tablets" (1 trials), "idebenone 150 mg film-coated tablets" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Reparto Di Neurologia dell'Osperdale Di Padova" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Reparto Di Neurologia dell'Osperdale Di Padova". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Reparto Di Neurologia dell'Osperdale Di Padova, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Reparto Di Neurologia dell'Osperdale Di Padova, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".